Back
Day Range
$242.75
$250.00
52-Week Range
$187.43
$322.34
Volume
705,467
50D / 200D Avg
$246.84
/
$252.44
Prev Close
$245.27
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 36.0 | 0.3 |
| P/B | 5.6 | 3.0 |
| ROE % | 16.9 | 3.7 |
| Net Margin % | 16.1 | 3.8 |
| Rev Growth 5Y % | 2.1 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$303.33
+22.8%
Low: $265.00
High: $340.00
Forward P/E
30.81
Forward EPS
$8.02
EPS Growth (est.)
+0.0%
Est. Revenue
3.25B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$11.36
$11.20 – $11.51
|
4.03B | 1 |
| FY2029 |
$11.11
$10.95 – $11.26
|
3.93B | 1 |
| FY2028 |
$10.14
$9.57 – $10.70
|
3.69B | 2 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-12 | $1.83 | $2.04 | +11.5% |
| 2025-10-23 | $1.68 | $1.96 | +16.7% |
| 2025-07-24 | $1.51 | $1.84 | +21.9% |
| 2025-04-24 | $1.22 | $1.45 | +18.9% |
| 2025-02-13 | $1.71 | $1.82 | +6.4% |
| 2024-10-24 | $1.50 | $1.85 | +23.3% |
| 2024-07-25 | $1.74 | $1.52 | -12.6% |
| 2024-04-25 | $1.26 | $1.56 | +23.8% |
Dividend History
7 yr streakYield
0.00%
Payout Ratio
0.12%
Growth (3Y)
5.20%
Growth (5Y)
5.51%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Apr 29, 2026 | May 06, 2026 | $0.22 | 0.35% |
| Jan 28, 2026 | Feb 04, 2026 | $0.22 | 0.36% |
| Nov 12, 2025 | Nov 19, 2025 | $0.22 | 0.31% |
| Jul 30, 2025 | Aug 06, 2025 | $0.21 | 0.34% |
| Apr 30, 2025 | May 07, 2025 | $0.21 | 0.39% |
| Feb 07, 2025 | Feb 11, 2025 | $0.21 | 0.26% |
| Nov 13, 2024 | Nov 20, 2024 | $0.21 | 0.24% |
| Jul 31, 2024 | Aug 07, 2024 | $0.20 | 0.26% |
| Apr 23, 2024 | May 01, 2024 | $0.20 | 0.20% |
| Jan 30, 2024 | Feb 07, 2024 | $0.20 | 0.21% |
| Nov 07, 2023 | Nov 15, 2023 | $0.20 | 0.23% |
| Jul 25, 2023 | Aug 02, 2023 | $0.19 | 0.20% |
| Apr 25, 2023 | May 03, 2023 | $0.19 | 0.21% |
| Jan 24, 2023 | Feb 01, 2023 | $0.19 | 0.29% |
| Nov 08, 2022 | Nov 16, 2022 | $0.19 | 0.33% |
| Jul 19, 2022 | Aug 03, 2022 | $0.18 | 0.24% |
| Apr 19, 2022 | May 04, 2022 | $0.18 | 0.19% |
| Jan 18, 2022 | Feb 02, 2022 | $0.18 | 0.19% |
| Nov 09, 2021 | Nov 17, 2021 | $0.18 | 0.17% |
| Jul 20, 2021 | Aug 04, 2021 | $0.17 | 0.18% |
Key Takeaways
Revenue grew 2.08% annually over 5 years — modest growth
ROE of 16.85% — decent returns on equity
Net margin of 16.06% shows strong profitability
Debt/Equity of 0.13 — conservative balance sheet
Generating 468.90M in free cash flow
P/E of 36.04 — premium valuation
Growth
Revenue Growth (5Y)
2.08%
Revenue (1Y)6.26%
Earnings (1Y)0.20%
FCF Growth (3Y)6.36%
Quality
Return on Equity
16.85%
ROIC12.89%
Net Margin16.06%
Op. Margin20.09%
Safety
Debt / Equity
0.13
Current Ratio3.02
Interest Coverage1029.00
Valuation
P/E Ratio
36.04
Forward P/E30.81
P/B Ratio5.60
EV/EBITDA28.21
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.26% | Revenue Growth (3Y) | 2.06% |
| Earnings Growth (1Y) | 0.20% | Earnings Growth (3Y) | -8.79% |
| Revenue Growth (5Y) | 2.08% | Earnings Growth (5Y) | -7.06% |
| Profitability | |||
| Revenue (TTM) | 3.07B | Net Income (TTM) | 493.70M |
| ROE | 16.85% | ROA | 11.56% |
| Gross Margin | 35.89% | Operating Margin | 20.09% |
| Net Margin | 16.06% | Free Cash Flow (TTM) | 468.90M |
| ROIC | 12.89% | FCF Growth (3Y) | 6.36% |
| Safety | |||
| Debt / Equity | 0.13 | Current Ratio | 3.02 |
| Interest Coverage | 1029.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.12% |
| Dividend Growth (3Y) | 5.20% | Dividend Growth (5Y) | 5.51% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 36.04 | Forward P/E | 30.81 |
| P/B Ratio | 5.60 | P/S Ratio | 5.79 |
| PEG Ratio | 34.00 | Forward PEG | N/A |
| EV/EBITDA | 28.21 | Fwd EV/EBITDA | 19.57 |
| Forward P/S | 5.48 | Fwd Earnings Yield | 3.25% |
| FCF Yield | 2.64% | ||
| Market Cap | 17.79B | Enterprise Value | 17.42B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.07B | 2.89B | 2.95B | 2.89B | 2.83B |
| Net Income | 493.70M | 492.70M | 593.40M | 585.90M | 661.80M |
| EPS (Diluted) | 6.80 | 6.69 | 7.88 | 7.73 | 8.67 |
| Gross Profit | 1.10B | 1.00B | 1.13B | 1.14B | 1.17B |
| Operating Income | 617.40M | 594.60M | 710.90M | 763.50M | 758.70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 4.27B | 3.64B | 3.83B | 3.62B | 3.31B |
| Total Liabilities | 1.09B | 961.10M | 948.50M | 931.90M | 978.40M |
| Shareholders' Equity | 3.18B | 2.68B | 2.88B | 2.68B | 2.34B |
| Total Debt | 416.70M | 305.30M | 309.00M | 317.90M | 325.30M |
| Cash & Equivalents | 791.30M | 484.60M | 853.90M | 894.30M | 762.60M |
| Current Assets | 1.98B | 1.54B | 1.94B | 1.92B | 1.74B |
| Current Liabilities | 654.90M | 550.40M | 671.80M | 519.00M | 594.10M |